ACAD - Company ID 0001070494
The table below shows ACADIA PHARMACEUTICALS INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $282.21M | $258.00M | $253.64M | $217.70M | $155.15M | $177.13M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $135.35M | $115.85M | $107.50M | $105.74M | $98.21M | $103.70M |
| Inventory | $112.29M | $105.98M | $110.53M | $102.97M | $86.74M | $86.07M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.10B |
| $1.08B |
| $960.55M |
| $870.94M |
| $788.28M |
| $728.92M |
| Property, plant & equipment | $14.65M | $3.71M | $3.55M | $3.50M | $3.99M | $4.14M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.61B | $1.33B | $1.23B | $1.13B | $976.87M | $914.10M |
| Accounts payable | $12.25M | $21.75M | $20.10M | $18.09M | $19.08M | $19.88M |
| Total current liabilities | $305.52M | $356.58M | $330.02M | $302.53M | $343.94M | $337.85M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $357.16M | $413.50M | $403.17M | $367.13M | $399.69M | $397.40M |
| Retained earnings | -$1.81B | -$2.09B | -$2.16B | -$2.19B | -$2.35B | -$2.38B |
| Total equity | $1.25B | $917.27M | $822.38M | $765.24M | $577.18M | $516.70M |